Author

Dalia M. Soueid

University of MichiganORCID 0000-0002-9929-1834Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:protein folding & dynamics· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

Amanda L. GarneriD· 2 shared Brandon J. C. Klein· 1 shared Gabriela Vega-Hernández· 1 shared Hui WangiD· 1 shared Jason C. RechiD· 1 shared Jesse Duque· 1 shared Wenhui ZhouiD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Amanda L. GarnerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CRISPR RiPCA for Investigating eIF4E-m7GpppX Capped mRNA Interactions

Gabriela Vega-Hernández, Jesse Duque, Brandon J. C. Klein, Dalia M. Soueid, Jason C. Rech, Hui Wang, Wenhui Zhou, Amanda L. Garner

This paper introduces CRISPR RiPCA, a platform combining CRISPR and live-cell RNA-protein interaction assays to measure inhibitor activity against eIF4E-m7GpppX interactions relevant to cancer drug discovery.

ACS Chemical Biology · Aug 7, 2025Peer-reviewedCell Biology

Adaptation of RiPCA for the Live-Cell Detection of mRNA-Protein Interactions

Dalia M. Soueid, Amanda L. Garner

This paper adapts the RiPCA technology to detect and screen mRNA-protein interactions in live cells, providing a guide for developing future assays for diverse interactions.

Biochemistry · Nov 14, 2023Peer-reviewedMolecular Biology